Skip to search formSkip to main contentSkip to account menu

alpha 1-Antitrypsin Injection [Glassia]

National Institutes of Health

Related topics

Related topics

3 relations
GlassiaInjection

Narrower (1)

alpha 1-proteinase inhibitor, human 1 MG Injection [Glassia]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes
Our aim was to assess the efficacy, safety, and tolerability of alpha-1 antitrypsin (AAT) as a therapeutic modality for β-cell… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)